Ritesh R Kotecha

25PUBLICATIONS
159CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Studies in religious traditions (excl. Eastern, Jewish, Christian and Islamic traditions)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 21, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

|Jul 29, 2026
Complete response to dual immune checkpoint blockade in a patient with Birt-Hogg-Dubé syndrome and epithelioid angiomyolipoma.

|Jul 14, 2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.

|Feb 26, 2026
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors.

Sophie A Hanina, Tyler Park, Michael Lopez

|Nov 14, 2025
The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs.

Treg Grubb, Pooneh Koochaki, Sayed Matar

|Mar 21, 2025
Utilization and perceptions of chaplaincy among hospitalized adults of Dharmic religions with cancer.

Rushil V Patel, Jill M Bowden, Danielle Boselli

Pageof 5

Frequent Collaborators

16 joint publications

Martin H Voss

13 joint publications

Robert J Motzer

7 joint publications

Maria Isabel Carlo

6 joint publications

Eduard Reznik